Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Transfusion, Autologous”

106 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 106 results

Not applicableStudy completedNCT01576263
What this trial is testing

Autologous Blood Transfusion After Local Infiltration

Who this might be right for
Total Hip ArthroplastyTotal Knee Arthroplasty
Northern Orthopaedic Division, Denmark 52
Early research (Phase 1)UnknownNCT03791372
What this trial is testing

Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Cerebral Palsy

Who this might be right for
Safety IssuesEffect of Drugs
Guangdong Women and Children Hospital 25
Not applicableStudy completedNCT04588350
What this trial is testing

Clinical Investigation Evaluating a New Autotransfusion Device in Cardiac Surgery

Who this might be right for
HemorrhageBlood LossSurgical Blood Loss
i-SEP 50
Early research (Phase 1)Ended earlyNCT04925206
What this trial is testing

A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia

Who this might be right for
Transfusion Dependent Beta-Thalassaemia
EdiGene (GuangZhou) Inc. 8
Large-scale testing (Phase 3)Study completedNCT00521664
What this trial is testing

A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups

Who this might be right for
Myeloid Leukemia
Technische Universität Dresden 400
Not applicableActive Not RecruitingNCT05145062
What this trial is testing

Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400.

Who this might be right for
Blood and Lymphatic Diseases
Sangamo Therapeutics 8
Not applicableLooking for participantsNCT05401175
What this trial is testing

Hematopoietic Stem Cell-containing Autologous Blood Transfusion for Bone Marrow Protection in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Chongqing University Cancer Hospital 40
Not applicableStudy completedNCT04304287
What this trial is testing

The Benefit of Autologous Blood Transfusion in Total Hip Arthroplasty

Who this might be right for
TransfusionHip Arthroplasty
Clinical Hospital Centre Zagreb 75
Not applicableLooking for participantsNCT06230198
What this trial is testing

The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery

Who this might be right for
Red Blood Cell Transfusion
Population Health Research Institute 4,500
Not applicableLooking for participantsNCT05773729
What this trial is testing

Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia

Who this might be right for
β-thalassemia
Shanghai BDgene Co., Ltd. 10
Post-approval studies (Phase 4)Study completedNCT04243681
What this trial is testing

Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis

Who this might be right for
Cirrhosis, Liver
Asian Institute of Gastroenterology, India 5
Large-scale testing (Phase 3)Study completedNCT02906202
What this trial is testing

A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype

Who this might be right for
Beta-Thalassemia
Genetix Biotherapeutics Inc. 24
Not applicableStudy completedNCT03720184
What this trial is testing

Haemo-autologous Antegrade Repriming (HAR) as Minimum Impact Perfusion Strategy for Cardiopulmonary Bypass

Who this might be right for
AnemiaCognitive; Disorder, Due to General Medical ConditionEmbolism, Air+4 more
Juan Blanco Morillo 116
Not applicableEnrolling By InvitationNCT06363760
What this trial is testing

A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

Who this might be right for
Sickle Cell DiseaseTransfusion-dependent Beta-ThalassemiaHemoglobinopathies
Editas Medicine, Inc. 54
Not applicableStudy completedNCT00004848
What this trial is testing

A Controlled Prospective Study of Transfusion-Associated Hepatitis

Who this might be right for
Hepatitis
National Institutes of Health Clinical Center (CC) 2,000
Not applicableLooking for participantsNCT05146726
What this trial is testing

Patient Blood Management Charité (PBM-Charité): Structured Detection, Differentiated Diagnostics and Therapy of Preoperative Anemia and Use of Machine Autotransfusion in Elective Interventions

Who this might be right for
Anemia
Charite University, Berlin, Germany 2,700
Large-scale testing (Phase 3)Looking for participantsNCT05477563
What this trial is testing

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

Who this might be right for
Beta-ThalassemiaThalassemiaHematologic Diseases+4 more
Vertex Pharmaceuticals Incorporated 26
Not applicableStudy completedNCT07207668
What this trial is testing

I-PRF & Root Surface Biomodification

Who this might be right for
Chronic Periodontitis (Disorder)Periodontitis
Halil Ata BIÇAKÇIOGLU 42
Large-scale testing (Phase 3)Study completedNCT00270062
What this trial is testing

Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery.

Who this might be right for
Anemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 77
Not applicableLooking for participantsNCT06355739
What this trial is testing

CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+

Who this might be right for
B Lymphocytic LeukemiaB Lymphoblastic Lymphoma
Zhu Xiaofan 60
Load More Results